Jim McCarter, Senior Managing Director of BioGenerator Ventures, sits down with Andrew Young, MD, PhD, of Pairidex and WashU, and Allyson Mayer, PhD, of Pairidex and BioGenerator Ventures.

Pairidex is the developer of a droplet digital PCR assay designed to enable accurate detection of gene fusions in blood cancer.

Innovators Hour, hosted by BioGenerator, the start-up arm of BioSTL, spotlights the people and ideas shaping St. Louis’ bioscience innovation ecosystem. Watch to discover groundbreaking startups, inspiring stories, and the future of bioscience in our region.

Want more BioSTL?

Website: biostl.org Newsletter: biostl.org/contact/contact-info-and-form

LinkedIn: linkedin.com/company/biostl

Jim McCarter, Senior Managing Director of BioGenerator Ventures, sits down with Geneoscopy co-founders Erica Barnell, MD, PhD, and Andrew Barnell, MBA.

Geneoscopy has developed a novel method to reliably extract and quantify eukaryotic RNA biomarkers in stool samples (seRNA). These seRNA biomarkers are being used to develop multiple assays that improve the ability to noninvasively evaluate gastrointestinal disease responses to eradicate cancer.

Innovators Hour, hosted by BioGenerator, the start-up arm of BioSTL, spotlights the people and ideas shaping St. Louis’ bioscience innovation ecosystem. Watch to discover groundbreaking startups, inspiring stories, and the future of bioscience in our region.

Want more BioSTL?

Website: biostl.org

Newsletter: biostl.org/contact/contact-info-and-form

LinkedIn: linkedin.com/company/biostl

Facebook: facebook.com/BioSTL/

Jim McCarter, Senior Managing Director of BioGenerator Ventures, sits down with entrepreneur and professor of biomedical engineering and chemistry, Dr. Cory Berkland of Bond Biosciences and WashU.

Bond Biosciences is a clinical-stage biopharmaceutical company focused on the discovery and development of first-in-class non-absorbed oral therapeutics that bind excess ions locally in the gastrointestinal (GI) tract to treat or prevent human disease.